CP
TNDM icon

Castleview Partners’s Tandem Diabetes Care TNDM Stock Holding History

Castleview Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$4K Buy
+40
New +$3.57K ﹤0.01% 815

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Castleview Partners's TNDM Position: Q2 2021 in Review

Castleview Partners opened a new position in Tandem Diabetes Care (TNDM) in Q2 2021: 40 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #815 among its holdings.

303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Castleview Partners held 40 shares of Tandem Diabetes Care worth $4K as of Q2 2021.
  • Tandem Diabetes Care was a new Castleview Partners position in Q2 2021.
  • Tandem Diabetes Care made up ﹤0.01% of Castleview Partners's portfolio in Q2 2021, its #815 holding.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.